Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150


Exploring Below the Tip of the Iceberg: The Prognostic Impact of Acute Exacerbations of COPD in Primary Care.

Aaron SD.

Am J Respir Crit Care Med. 2018 Mar 12. doi: 10.1164/rccm.201802-0372ED. [Epub ahead of print] No abstract available.


Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.

Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN).

Respir Res. 2018 Feb 14;19(1):30. doi: 10.1186/s12931-018-0733-z.


Health Services Burden of Undiagnosed and Overdiagnosed COPD.

Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network.

Chest. 2018 Feb 6. pii: S0012-3692(18)30238-1. doi: 10.1016/j.chest.2018.01.038. [Epub ahead of print]


Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.

Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS.

Br J Clin Pharmacol. 2018 Mar;84(3):579-589. doi: 10.1111/bcp.13465. Epub 2017 Dec 6.


Mucolytics for COPD: negotiating a slippery slope towards proof of efficacy.

Aaron SD.

Eur Respir J. 2017 Oct 12;50(4). pii: 1701465. doi: 10.1183/13993003.01465-2017. Print 2017 Oct. No abstract available.


Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study.

Gershon AS, Macdonald EM, Luo J, Austin PC, Gupta S, Sivjee K, Upshur R, Aaron SD.

Fam Pract. 2017 Nov 16;34(6):708-716. doi: 10.1093/fampra/cmx058.


CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise.

Washko GR, Coxson HO, O'Donnell DE, Aaron SD.

Lancet Respir Med. 2017 Nov;5(11):903-908. doi: 10.1016/S2213-2600(17)30345-4. Epub 2017 Sep 28.


Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.


A first step to STOP cystic fibrosis exacerbations.

Burgel PR, Reid DW, Aaron SD.

J Cyst Fibros. 2017 Sep;16(5):529-531. doi: 10.1016/j.jcf.2017.08.006. No abstract available.


Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.


Reaching for the Holy Grail of Chronic Obstructive Pulmonary Disease Outcomes. Can Medications Modify Lung Function Decline?

Aaron SD.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):2-4. doi: 10.1164/rccm.201708-1549ED. No abstract available.


Increased prevalence of colonic adenomas in patients with cystic fibrosis.

Hegagi M, Aaron SD, James P, Goel R, Chatterjee A.

J Cyst Fibros. 2017 Nov;16(6):759-762. doi: 10.1016/j.jcf.2017.07.009. Epub 2017 Jul 23.


The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis.

Chin M, Aaron SD, Bell SC.

Presse Med. 2017 Jun;46(6 Pt 2):e139-e164. doi: 10.1016/j.lpm.2016.11.030. Epub 2017 May 31. Review.


Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.

Ra SW, Sze MA, Lee EC, Tam S, Oh Y, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Sin DD; Canadian Respiratory Research Network.

Respir Res. 2017 May 30;18(1):109. doi: 10.1186/s12931-017-0594-x.


Reassessment of an Asthma Diagnosis-Reply.

Aaron SD.

JAMA. 2017 May 2;317(17):1802. doi: 10.1001/jama.2017.3507. No abstract available.


Blood Pressure Medications to Prevent Emphysema? Take These Pills with a Grain of Salt.

Aaron SD.

Ann Am Thorac Soc. 2017 May;14(5):619-620. doi: 10.1513/AnnalsATS.201701-023ED. No abstract available.


Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease.

Leitao Filho FS, Won Ra S, Mattman A, Schellenberg RS, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Man SFP, Aaron SD, Reed RM, Sin DD.

J Allergy Clin Immunol. 2017 Oct;140(4):1164-1167.e6. doi: 10.1016/j.jaci.2017.01.046. Epub 2017 Apr 27. No abstract available.


Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.

Kahn SR, Akaberi A, Granton JT, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Hirsch AM.

Am J Med. 2017 Aug;130(8):990.e9-990.e21. doi: 10.1016/j.amjmed.2017.03.033. Epub 2017 Apr 8.


Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing.

Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD; Canadian Respiratory Research Network.

CMAJ. 2017 Apr 10;189(14):E530-E538. doi: 10.1503/cmaj.151420. Epub 2016 Nov 14.


N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.

Ma K, Kahn SR, Hirsch AM, Akaberi A, Anderson DR, Wells PS, Rodger M, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Granton JT.

Thromb Res. 2017 May;153:47-49. doi: 10.1016/j.thromres.2017.03.005. Epub 2017 Mar 8. No abstract available.


Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality.

Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

PLoS One. 2017 Mar 16;12(3):e0173830. doi: 10.1371/journal.pone.0173830. eCollection 2017.


Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.

Aaron SD, Tan WC, Bourbeau J, Sin DD, Loves RH, MacNeil J, Whitmore GA; Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2017 Aug 1;196(3):306-314. doi: 10.1164/rccm.201612-2531OC.


A clinical tool to calculate post-transplant survival using pre-transplant clinical characteristics in adults with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Chaparro C, Aaron SD, Whitmore GA, Stanojevic S.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12950. Epub 2017 Apr 23.


Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Bourbeau J, Aaron SD, Barnes NC, Davis KJ, Lacasse Y, Nadeau G.

Respir Med. 2017 Feb;123:94-97. doi: 10.1016/j.rmed.2016.12.015. Epub 2016 Dec 23. Review.


Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S, Alvarez GG, Pakhale S, Mallick R, Boulet LP; Canadian Respiratory Research Network.

JAMA. 2017 Jan 17;317(3):269-279. doi: 10.1001/jama.2016.19627.


Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Wells GA.

Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141.


Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study.

Kahn SR, Hirsch AM, Akaberi A, Hernandez P, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Geerts WH, Aaron SD, Granton JT.

Chest. 2017 May;151(5):1058-1068. doi: 10.1016/j.chest.2016.11.030. Epub 2016 Dec 6.


Changes in the Cystic Fibrosis Airway Microbiome after Lung Transplant: The More Things Change, the More They Stay the Same.

Aaron SD.

Ann Am Thorac Soc. 2016 Dec;13(12):2109-2110. No abstract available.


Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Tan WC, Hague CJ, Leipsic J, Bourbeau J, Zheng L, Li PZ, Sin DD, Coxson HO, Kirby M, Hogg JC, Raju R, Road J, O'Donnell DE, Maltais F, Hernandez P, Cowie R, Chapman KR, Marciniuk DD, FitzGerald JM, Aaron SD; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

PLoS One. 2016 Nov 18;11(11):e0166745. doi: 10.1371/journal.pone.0166745. eCollection 2016.


Influence of country-level differences on COPD prevalence.

Aaron SD, Gershon AS, Gao Y, Yang J, Whitmore GA.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2305-2313. eCollection 2016.


Addressing the misdiagnosis of asthma in adults: where does it go wrong?

MacNeil J, Loves RH, Aaron SD.

Expert Rev Respir Med. 2016 Oct 8:1-12. [Epub ahead of print]


The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study.

Kendzerska T, To TM, Aaron SD, Lougheed MD, Sadatsafavi M, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

J Allergy Clin Immunol. 2017 Mar;139(3):835-843. doi: 10.1016/j.jaci.2016.06.026. Epub 2016 Sep 15.


COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.

Leung JM, Chen V, Hollander Z, Dai D, Tebbutt SJ, Aaron SD, Vandemheen KL, Rennard SI, FitzGerald JM, Woodruff PG, Lazarus SC, Connett JE, Coxson HO, Miller B, Borchers C, McManus BM, Ng RT, Sin DD.

PLoS One. 2016 Aug 15;11(8):e0161129. doi: 10.1371/journal.pone.0161129. eCollection 2016.


The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?

Gupta N, Pinto L, Benedetti A, Li PZ, Tan WC, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL, Bourbeau J; Canadian Respiratory Research Network and the CanCOLD Collaborative Research Group.

Chest. 2016 Nov;150(5):1069-1079. doi: 10.1016/j.chest.2016.06.016. Epub 2016 Jun 27.


Factors associated with undiagnosed and overdiagnosed COPD.

Gershon AS, Hwee J, Chapman KR, Aaron SD, O'Donnell DE, Stanbrook MB, Bourbeau J, Tan W, Su J, Victor JC, To T.

Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23. No abstract available.


Referral to lung transplantation--too little, too late.

Aaron SD, Chaparro C.

J Cyst Fibros. 2016 Mar;15(2):143-4. doi: 10.1016/S1569-1993(16)00020-5. No abstract available.


Lost in translation? How adults living with Cystic Fibrosis understand treatment recommendations from their healthcare providers, and the impact on adherence to therapy.

Pakhale S, Baron J, Armstrong M, Tasca G, Gaudet E, Aaron SD, Cameron W, Balfour L.

Patient Educ Couns. 2016 Aug;99(8):1319-24. doi: 10.1016/j.pec.2016.03.023. Epub 2016 Mar 23.


Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.

Huus KE, Joseph J, Zhang L, Wong A, Aaron SD, Mah TF, Sad S.

J Immunol. 2016 Apr 1;196(7):3097-108. doi: 10.4049/jimmunol.1501642. Epub 2016 Feb 19.


A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.

Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE, Elborn JS.

J Cyst Fibros. 2016 Jul;15(4):495-502. doi: 10.1016/j.jcf.2015.12.004. Epub 2016 Feb 4.


Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.

Labonté LE, Tan WC, Li PZ, Mancino P, Aaron SD, Benedetti A, Chapman KR, Cowie R, FitzGerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell D, Sin D, Bourbeau J; Canadian Respiratory Research Network; CanCOLD Collaborative Research Group.

Am J Respir Crit Care Med. 2016 Aug 1;194(3):285-98. doi: 10.1164/rccm.201509-1795OC.


History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.

Sadatsafavi M, Tavakoli H, Kendzerska T, Gershon A, To T, Aaron SD, FitzGerald JM; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.


A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Cowan J, Gaudet L, Mulpuru S, Corrales-Medina V, Hawken S, Cameron C, Aaron SD, Cameron DW.

PLoS One. 2015 Nov 11;10(11):e0142205. doi: 10.1371/journal.pone.0142205. eCollection 2015.


Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Laroche J, Larose S, Maaroufi H, Fothergill JL, Moore M, Winsor GL, Aaron SD, Barbeau J, Bell SC, Burns JL, Camara M, Cantin A, Charette SJ, Dewar K, Déziel É, Grimwood K, Hancock RE, Harrison JJ, Heeb S, Jelsbak L, Jia B, Kenna DT, Kidd TJ, Klockgether J, Lam JS, Lamont IL, Lewenza S, Loman N, Malouin F, Manos J, McArthur AG, McKeown J, Milot J, Naghra H, Nguyen D, Pereira SK, Perron GG, Pirnay JP, Rainey PB, Rousseau S, Santos PM, Stephenson A, Taylor V, Turton JF, Waglechner N, Williams P, Thrane SW, Wright GD, Brinkman FS, Tucker NP, Tümmler B, Winstanley C, Levesque RC.

Front Microbiol. 2015 Sep 29;6:1036. doi: 10.3389/fmicb.2015.01036. eCollection 2015.


Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients.

Mulpuru S, Aaron SD, Ronksley PE, Lawrence N, Forster AJ.

Emerg Infect Dis. 2015 Aug;21(8):1366-71. doi: 10.3201/eid2108.140978.


Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S.

J Heart Lung Transplant. 2015 Sep;34(9):1139-45. doi: 10.1016/j.healun.2015.05.003. Epub 2015 May 7.


Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.

Tan WC, Sin DD, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, Marciniuk DD, Maltais F, Buist AS, Road J, Hogg JC, Kirby M, Coxson H, Hague C, Leipsic J, O'Donnell DE, Aaron SD; CanCOLD Collaborative Research Group.

Thorax. 2015 Sep;70(9):822-9. doi: 10.1136/thoraxjnl-2015-206938. Epub 2015 Jun 5.


Walking a tightrope: targeting neutrophils to treat chronic obstructive pulmonary disease.

Aaron SD.

Am J Respir Crit Care Med. 2015 May 1;191(9):971-2. doi: 10.1164/rccm.201502-0361ED. No abstract available.


The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada.

Alvarez GG, Dyk DDV, Desjardlns M, Yasseen AS 3rd, Aaron SD, Cameron DW, Obed N, Baikie M, Pakhale S, Denklnger CM, Sohn H, Pal M.

Chest. 2015 Sep;148(3):767-773. doi: 10.1378/chest.14-2948.


Effects of weight loss on airway responsiveness in obese adults with asthma: does weight loss lead to reversibility of asthma?

Pakhale S, Baron J, Dent R, Vandemheen K, Aaron SD.

Chest. 2015 Jun;147(6):1582-1590. doi: 10.1378/chest.14-3105.


Supplemental Content

Loading ...
Support Center